ÆÄŲ½¼º´ ȯÀÚ¿¡¼ ³«»ó±º°ú ºñ³«»ó±º¿¡ ´ëÇÑ ¹ö±×±ÕÇü°Ë»çÀÇ Å¸´çµµ
Validating the Berg Balance Test for Patients with Parkinson¡¯s Disease
Á¶±ÔÇà, ¿ì¿µ±Ù, Ȳ¼öÁø,
¼Ò¼Ó »ó¼¼Á¤º¸
禱 ( Cho GYU-Hang )
±¹¸³ÀçÈ°¿ø ¹°¸®Ä¡·á½Ç
¿ì¿µ±Ù ( Woo Young-Keun )
ÀüÁÖ´ëÇб³ ´ëüÀÇÇдëÇÐ ¹°¸®Ä¡·áÇаú
Ȳ¼öÁø ( Hwang Su-Jin )
¿¬¼¼´ëÇб³ º¸°Ç°úÇבּ¸¼Ò
KMID : 1002720110090030031
Abstract
Purpose£º The purpose of this study was to evaluate the criterion-related validity of the Berg balance test between fallers and non-fallers in individuals with Parkinson¡¯s disease.
Methods£º Thirty-one patients were recruited for this study. Their initial diagnosis had been made on average 30.1¡¾10.1 years earlier. Score of Berg balance test showed significant correlations with indicators of motor functioning and daily living capacity. Berg balance test score was inversely associated with the unified Parkinson¡¯s disease rating scale-motor score, and Schwab and England activities of daily living rating scale.
Results£º In all 3 correlations, lower scores on the Berg balance test correlated with higher unified Parkinson¡¯s disease rating scale-motor scores. Results support the criterion-related validity of the Berg balance test.
Conclusion£º Our research results agree with other published research in suggesting that the Berg balance test may be used as a screening tool and ongoing assessment tool for patients with Parkinson¡¯s disease.
Å°¿öµå
Balance; Berg balance test; Parkinson¡¯s disease; Schwab and England activities of daily living; Unified Parkinson¡¯s disease rating scale
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸